192 related articles for article (PubMed ID: 31229653)
1. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.
Lao Q; Brookner B; Merke DP
J Mol Diagn; 2019 Sep; 21(5):924-931. PubMed ID: 31229653
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency.
Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442
[TBL] [Abstract][Full Text] [Related]
3. Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia.
Morissette R; Chen W; Perritt AF; Dreiling JL; Arai AE; Sachdev V; Hannoush H; Mallappa A; Xu Z; McDonnell NB; Quezado M; Merke DP
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1143-52. PubMed ID: 26075496
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X.
Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP
BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125
[TBL] [
